Kornpong Vantanasiri

ORCID: 0000-0001-7882-4294
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Esophageal Cancer Research and Treatment
  • Esophageal and GI Pathology
  • Gastric Cancer Management and Outcomes
  • Pancreatitis Pathology and Treatment
  • Bariatric Surgery and Outcomes
  • Gastrointestinal Tumor Research and Treatment
  • Eosinophilic Esophagitis
  • Pancreatic and Hepatic Oncology Research
  • Gastroesophageal reflux and treatments
  • Gallbladder and Bile Duct Disorders
  • Obesity and Health Practices
  • Abdominal vascular conditions and treatments
  • Dialysis and Renal Disease Management
  • Thyroid and Parathyroid Surgery
  • Appendicitis Diagnosis and Management
  • Gastrointestinal disorders and treatments
  • Nutrition and Health in Aging
  • Parathyroid Disorders and Treatments
  • Colorectal and Anal Carcinomas
  • Clostridium difficile and Clostridium perfringens research
  • Helicobacter pylori-related gastroenterology studies
  • Organ and Tissue Transplantation Research
  • Lymphoma Diagnosis and Treatment
  • Stoma care and complications
  • CNS Lymphoma Diagnosis and Treatment

Mayo Clinic in Arizona
2024-2025

Mayo Clinic in Florida
2022-2025

WinnMed
2023-2024

Mayo Clinic
2023-2024

RELX Group (Netherlands)
2024

Siriraj Hospital
2021-2022

Mahidol University
2021-2022

University of Minnesota
2019-2021

Minnesota Gastroenterology
2020

Background and study aims: Although endoscopic submucosal dissection (ESD) is associated with higher en-bloc R0 resection rates than cap-assisted mucosal (cEMR), its comparative impact on achieving complete remission of dysplasia (CRD) intestinal metaplasia (CRIM) in BE eradication therapy (EET) not well defined. We aimed to compare the journey patients from initial (ER) ESD cEMR CRD CRIM. Patients methods: undergoing or followed by ablation for neoplasia at two academic institutions United...

10.1055/a-2422-2815 article EN cc-by Endoscopy International Open 2025-03-17

INTRODUCTION: Endoscopic eradication therapy (EET) is standard of care for T1a esophageal adenocarcinoma (EAC). However, data on outcomes in high-risk EAC are limited. We assessed and compared after EET low-risk EAC, including intraluminal recurrence, extraesophageal metastases, overall survival. METHODS: Patients who underwent at 3 referral Barrett's esophagus endotherapy units between 1996 2022 were included. with submucosal invasion, positive deep margins, or metastases initial diagnosis...

10.14309/ajg.0000000000002554 article EN The American Journal of Gastroenterology 2023-10-05

Objectives We aimed to estimate the incidence of new-onset diabetes (NOD) and identify risk factors for NOD in patients with necrotizing pancreatitis (NP). Methods Necrotizing were reviewed NOD, diagnosed >90 days after acute pancreatitis. Baseline demographics, comorbidities, clinical outcomes, computed tomography (CT) characteristics necrotic collections, CT-derived abdominal fat measurements analyzed predictors NOD. Results Among 390 eligible NP (66% men; median age, 51 years;...

10.1097/mpa.0000000000002292 article EN Pancreas 2024-01-24

INTRODUCTION: Endoscopic eradication therapy (EET) combining endoscopic resection (ER) with mucosal (EMR) or submucosal dissection (ESD) followed by ablation is the standard of care for treatment dysplastic Barrett's esophagus (BE). We have previously shown comparable rates complete remission intestinal metaplasia (CRIM) both approaches. However, data comparing recurrence after CRIM are lacking. compared techniques in a multicenter cohort. METHODS: Patients undergoing EET achieving at 3...

10.14309/ajg.0000000000002798 article EN The American Journal of Gastroenterology 2024-04-08

Fecal microbiota transplantation (FMT) is a highly effective treatment for recurrent Clostridioides difficile infection (rCDI). However, standardization of FMT products essential its broad implementation into clinical practice. We have developed an oral preparation freeze-dried, encapsulated microbiota, which ~ 80% clinically effective, but results in delayed engraftment donor bacteria relative to administration via colonoscopy. Our objective was measure the potential freeze-dried without...

10.1038/s41598-021-84152-6 article EN cc-by Scientific Reports 2021-02-25

Severe hyperparathyroidism predicts poor outcomes in patients with kidney failure. Mechanisms underlying the relationship between high parathyroid hormone (PTH) and decreased survival other than bone loss are largely unexplored. Recent evidence suggests role of excess PTH adipose tissue browning resulting protein-energy wasting. The present retrospective observational study examined nutritional status among receiving maintenance hemodialysis different degree hyperparathyroidism. Seven...

10.3389/fnut.2022.933918 article EN cc-by Frontiers in Nutrition 2022-09-13
Coming Soon ...